Consortium members profile
| Picture | Full Name and Degrees | Institutional affiliation | Research hub |
|---|---|---|---|
 |
George Q. Daley, M.D., Ph.D. | Children's Hospital Boston | iPS and Progenitor Cell Models |
 |
Alan D. Friedman, M.D. | Johns Hopkins University | iPSC Hematologic and Vascular Therapies |
 |
Punam Malik, M.D. | CCHMC | Cell Characterization Core |
 |
Joseph Metzger, Ph.D. | University of Minnesota | Programming and Reprogramming: CV and HSC Fate |
 |
Mortimer Poncz, M.D. | Children's Hospital of Philadelphia | ESC Platelet Therapeutics |
 |
Jay W. Schneider, M.D., Ph.D. | UT Southwestern Medical Center | Microenvironmental Control of Progenitors |
 |
Michael L. Terrin, M.D., C.M., M.P.H. | University of Maryland | Administrative Coordinating Center |
 |
James A. Thomson, M.D., Ph.D. | University of Wisconsin | Programming and Reprogramming: CV and HSC Fate |
 |
Irving Weissman, M.D. | Stanford University | Progenitor Cells and their Niches |
 |
Joseph Wu, M.D., Ph.D. | Stanford-Gladstone | iPS Cells in Heart Disease |
Pages
Copyright ©2013 NHLBI Progenitor Cell Biology Consortium.
